Twofold higher risk seen for diabetes patients with a severe hypoglycemia event

Findings particularly strong for lowering risk for diabetic retinopathy

Glucose level within target range for greater percentage of time than with sensor-augmented insulin pump

Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes

Relationship modified by overall sleep patterns, especially with daytime sleepiness

Metformin preferred as initial agent; early combined therapy can extend time to treatment failure

Exposure to maternal polycystic ovary syndrome tied to higher risk for neurodevelopmental disorders

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Lung-Specific Risk …

Severity of presentation with diabetic ketoacidosis higher in 2020 versus 2019

Risk lower for those who dropped from obese to overweight versus those who remained obese